BRIDGEBIOPHARMA
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated . These are the last published financial totals; newer source data is not included yet.
Across this cycle, 98,314 contributions come from electronic filings the FEC has not yet processed into its bulk data; those rows are replaced by the FEC version when it does.
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under BRIDGEBIOPHARMA.
Showing the last published contribution snapshot. Newer source data is not included yet.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for BridgeBio Pharma, Inc.. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–6 of 6 · largest absolute amount first
Evidence-based cluster of 3 reported identities; not a verified identity merge · CLARKSVILLE, MD, 21029 · BRIDGEBIO PHARMA · Healthcare & Pharmaceuticals · CHIEF REGULATORY OFFICER · Reported as NDU, ADORA / NDU, ADORA DR. · 3 transaction rows
99% Republican · 0% unclassifiedDerived from contributionsEvidence-based cluster of 2 reported identities; not a verified identity merge · GEYSERVILLE, CA, 95441 · BRIDGEBIO PHARMA · Healthcare & Pharmaceuticals · BIOTECH EXECUTIVE · Reported as FOX, JONATHAN C / FOX, JONATHAN C. · 3 transaction rows
DemocraticDerived from contributionsReported name + ZIP cluster; not a verified identity merge · MILTON, MA, 02186 · BRIDGEBIO PHARMA, INC. · Healthcare & Pharmaceuticals · ATTORNEY · 4 transaction rows
DemocraticDerived from contributionsReported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20003 · BRIDGEBIO PHARMA · Healthcare & Pharmaceuticals · VICE PRESIDENT, POLICY ADVOCACY · 4 transaction rows
RepublicanDerived from contributionsReported name + ZIP cluster; not a verified identity merge · SAN RAFAEL, CA, 94901 · BRIDGEBIO PHARMA INC · Healthcare & Pharmaceuticals · GENERAL COUNSEL · 6 transaction rows
DemocraticDerived from contributionsReported name + ZIP cluster; not a verified identity merge · IRVINE, CA, 92618 · BRIDGEBIO PHARMA · Healthcare & Pharmaceuticals · PHYSICIAN DRUG DEVELOPMENT · 1 transaction rows
46% Democratic / 54% RepublicanDerived from contributionsWhere the contributions went · 10 per page
Showing 11–12 of 12 · largest absolute amount first
Senate campaign committee · SAVANNAH, GA · CARTER, EARL LEROY · U.S. Senate GA 00 · 1 transaction rows
RepublicanDerived from contributionsPAC (qualified) · WASHINGTON, DC · 1 transaction rows
46% Democratic / 54% RepublicanDerived from contributionsReported as BRIDGEBIOPHARMA
Industry classification summary
BridgeBio Pharma is a biopharmaceutical company focused on genetic diseases and cancers, as documented on their website and third-party company profiles.
AI-generated classification based on saved sources
View source